• *** Important Alert *** Beware of fraudulent messages or websites — only trust communications from SICOT official websites and our official partners: K.I.T. Group, Congrès Inc & Medical Conference Partners.

abstract categories

  • Antiretroviral drugs preclinical
  • HIV cure and reservoirs
  • HIV diagnostics
  • Immunology
  • Pathogenesis and immunopathogenesis
  • Vaccines and immune based therapies
  • Virology
  • Virus evolution and phylodynamic studies
  • Antiretroviral therapy – observational studies
  • Antiretroviral therapy – randomised clinical trials
  • Treatment in resource-constrained settings
  • Drug-drug interactions
  • HIV drug resistance
  • Pharmacology/Pharmaco Genomics
  • Toxicities
  • COVID-19 and HIV
  • Other co-infections
  • Sexually transmitted infections
  • Tuberculosis and other opportunistic infections
  • Viral hepatitis
  • Vaccination
  • Mpox and emerging infectious diseases
  • Ageing and frailty
  • Co-morbidities
  • Neoplasia
  • Mental health and quality of life
  • Adolescents
  • Paediatrics
  • Pregnancy and breastfeeding
  • Antenatal screening
  • Access and delivery of care
  • Cascade of care
  • Morbidity/mortality
  • Prevalence, incidence and dynamics of HIV epidemics
  • Implementation science
  • HIV testing strategies, including co-testing
  • Pre-exposure prophylaxis (PrEP)
  • Post-exposure prophylaxis (PEP)
  • Treatment as prevention
  • Lifestyle interventions
  • Migration
  • War and other conflicts
  • Behavioural science
  • Sex work
  • Substance abuse
  • Vulnerable and marginalised groups
  • Cis and transgender issues
  • Men who have sex with men
SCIENTIFIC PROGRAMME
REGISTER NOW